The Neurotechnology Industry Report 2007
Table of Contents

1: Executive Summary

The Brain Industry Revealed
Investment Risks and Opportunities
Neurotechnology and Society
Key Industry Facts and Findings
Timeline of Advances in Neuroscience

2: Trends and Drivers

Converging Technologies
- Stem Cells and Neuroregeneration
- Neuroimaging and Disease Treatment
- Crossing the Blood Brain Barrier

Demographic Drivers
- More People Living Longer

Social Drivers
- The Life Style Improvement Market

Economic Drivers
- Worldwide Economic Burden
- Rising Healthcare Costs

Research Funding
- United States Government
- International Research Funding
- Foundations Focus on the Brain

Regulatory Trends
- International Regulatory Competition

Intellectual Property Trends
- Global Intellectual Property Protection
- Neuropharmaceutical Patent Expirations
- Patent Activity in the US: 1980-2004
- Selected Neurotechnology Patents

3: Neuropharmaceutical Sector

Cogniceutical Market
- Alzheimer's Disease
- Mild Cognitive Impairment
- Attention Deficit Disorders
- Sleep Disorders

Emoticeutical Market
- Depression
- Anxiety Disorders

Sensoceutical Market
- Chronic Pain
- Retinal and Optic Nerve Disorders
- Epilepsy and Seizure Disorders
- Parkinson's Disease

Other Markets
- Schizophrenia and Psychosis
- Addiction and Substance Abuse
- Obesity
- Stroke

4: Neurodevice Sector

Neuroprosthetic Devices
- Cochlear Implants
- Retinal Implants
- Motor Prostheses & Brain-Computer Interface

Neurostimulation Devices
- Brain Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
- Peripheral Nerve Stimulation

Neurosurgical Devices
- Neurosurgical Navigation Equipment
- Radiosurgical Devices
- Neurovascular Intervention

Neurosoftware
- Attention Deficit Disorders
- Pain Control
- Age-related Disorders

5: Neurodiagnostic Sector
 
 Neuroimaging
 - Computed Tomography (CT)
 - Magnetic Resonance Imaging (MRI, fMRI)
 - Nuclear Medicine Imaging (PET, SPECT)
 - Electroencephalography (EEG)
 - Magnetoencephalography (MEG)
 
 In Vitro Diagnostics
 - Genetic Testing and Pharmacogenomics
 - Protein Biomarker Assays
 
 Neuroinformatics
 - Patient Dataset Management
 - Open Source Software
 
6: Private Neurotech Investment

 U.S. Venture Capital Investment 1999-2004
 Neurotech Venture Capital 1999-2004
 Largest Neurotech Investments 1999-2004 
 Leading Neurotech Venture Capital Firms
 
 7: Public Neurotech Investment

 Neurotech Initial Public Offerings 2004-Q12006
 Neurotech M&A activity
 Neuropharma Research and Licensing Deals
 NeuroInsights' Neurotech Index
 Neurotech Index Performance
 
 8: Leading Research Centers

University of California, San Francisco (UCSF)
Massachusetts Institute of Technology (MIT)
University of California, San Diego (UCSD)
Harvard University
Stanford University
University of California, Los Angeles (UCLA)
Columbia University
University College London (UCL)
Karolinska Institutet, Stockholm
RIKEN Brain Science Institute, Japan 
Places to Watch

9: Leading Neurotechnology Regions
 
 The Global Neurotech Economy
 Nexus Ranking and Methodology
 Establish Neurotech Nexus'
 Emerging Neurotech Nexus'
 Nascent Neurotech Nexus' 
 Conclusions and Policy Recommendations

10: Company Profiles

 Neuropharmaceutical Companies
 - Private
 - Public
 Neurodevice Companies
 - Private
 - Public
 Neurodiagnostic Companies
 - Private
 - Public